On 1 July 2026, WinQure Medicine’s Chief Scientific Officer, Dr Henrik Ørum, will be speaking at Copenhagen University Hospital (Rigshospitalet).
The presentation will provide an overview of WinQure’s platform for individualized genetic medicines, including our approach to therapeutic development, clinical trial setup, and the regulatory pathways enabling treatments for patients with ultra-rare genetic diseases.
Dr Ørum will also share insights from more than 25 years of experience in antisense drug development and the future potential of nucleic acid therapeutics.
The event provides an opportunity to engage with clinicians, researchers, and healthcare professionals on the future of precision medicine and rare disease treatment.